Involvement of DARPP-32 phosphorylation in the stimulant action of caffeine (original) (raw)

References

  1. Fredholm, B. B., Battig, K., Holmen, J., Nehlig, A. & Zvartau, E. E. Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. Pharmacol. Rev. 51, 83–133 (1999)
    CAS PubMed Google Scholar
  2. Walaas, S. I., Aswad, D. W. & Greengard, P. DARPP-32, a dopamine- and cAMP-regulated phosphoprotein enriched in dopamine-innervated brain regions. Nature 301, 69–71 (1983)
    Article CAS Google Scholar
  3. Gerfen, C. R. The neostriatal mosaic: multiple levels of compartmental organization in the basal ganglia. Annu. Rev. Neurosci. 15, 285–320 (1992)
    Article CAS Google Scholar
  4. Schiffman, S. N. & Vanderhaeghen, J.-J. Adenosine A2 receptors regulate the gene expression of striatopallidal and striatonigral neurons. J. Neurosci. 13, 1080–1087 (1993)
    Article Google Scholar
  5. Fink, J. S. et al. Molecular cloning of the rat A2 adenosine receptor: selective co-expression with D2 dopamine receptor in rat striatum. Mol. Brain Res. 14, 186–195 (1992)
    Article CAS Google Scholar
  6. Kull, B., Svenningsson, P. & Fredholm, B. B. Adenosine A2A receptors are colocalized with and activate Golf in rat striatum. Mol. Pharmacol. 58, 771–777 (2000)
    Article CAS Google Scholar
  7. Fredholm, B. B. Activation of adenylate cyclase from rat striatum and tuberculum olfactorium by adenosine. Med. Biol. 55, 262–267 (1977)
    CAS PubMed Google Scholar
  8. Ledent, C. et al. Aggressiveness, hypoalgesia and increased blood pressure in mice deficient for the adenosine A2a receptor. Nature 388, 674–678 (1997)
    Article CAS Google Scholar
  9. El Yacoubi, M. et al. The stimulant effects of caffeine on locomotor behaviour in mice are mediated through its blockade of adenosine A(2A) receptors. Br. J. Pharmacol. 129, 1465–1473 (2000)
    Article CAS Google Scholar
  10. Ouimet, C. C., Langley-Guillion, K.-C. & Greengard, P. Quantitative immunochemistry of DARPP-32-expressing neurons in the rat caudatoputamen. Brain Res. 808, 8–12 (1998)
    Article CAS Google Scholar
  11. Snyder, S. H., Katims, J. J., Annau, Z., Bruns, R. F. & Daly, J. W. Adenosine receptors and the behavioural actions of methylxanthines. Proc. Natl Acad. Sci. USA 78, 3260–3264 (1981)
    Article CAS Google Scholar
  12. Bibb, J. et al. Phosphorylation of DARPP-32 by Cdk5 modulates dopamine signalling in neurons. Nature 402, 669–671 (1999)
    Article CAS Google Scholar
  13. Nishi, A., Snyder, G. L., Nairn, A. C. & Greengard, P. Role of calcineurin and protein phosphatase-2A in the regulation of DARPP-32 dephosphorylation in neostriatal neurons. J. Neurochem. 72, 2015–2021 (1999)
    Article CAS Google Scholar
  14. Nishi, A. et al. Amplification of dopaminergic signalling by a positive feedback loop. Proc. Natl Acad. Sci. USA 97, 12840–12845 (2000)
    Article CAS Google Scholar
  15. Ongini, E. SCH 58261: a selective A2A adenosine receptor antagonist. Drug Dev. Res. 42, 63–70 (1997)
    Article CAS Google Scholar
  16. Ehrlich, M. E., Kurihara, T. & Greengard, P. Rat DARPP-32: cloning, sequencing, and characterization of the cDNA. J. Mol. Neurosci. 2, 1–10 (1990)
    Article CAS Google Scholar
  17. Le Moine, C. & Bloch, B. D1 and D2 dopamine receptors gene expression in the rat striatum: sensitive cRNA probes demonstrate prominent segregation of D1 and D2 mRNA in distinct neuronal population of the dorsal and ventral striatum. J. Comp. Neurol. 355, 418–427 (1995)
    Article CAS Google Scholar
  18. Svenningsson, P. et al. Dopamine D1 receptor-induced gene transcription is modulated by DARPP-32. J. Neurochem. 75, 248–257 (2000)
    Article CAS Google Scholar
  19. Ögren, S.-Ö., Köhler, C., Fuxe, K. & Ängeby, K. in Dopaminergic Ergot Derivatives and Motor Function (eds Fuxe, K. & Calne, D. B.) 225–266 (Pergamon, Oxford, 1979)
    Google Scholar
  20. Fienberg, A. A. et al. DARPP-32: regulator of the efficacy of dopaminergic neurotransmission. Science 281, 838–842 (1998)
    Article CAS Google Scholar
  21. Hemmings, H. C. J. & Greengard, P. DARPP-32, a dopamine- and adenosine 3′:5′-monophosphate-regulated phosphoprotein: regional, tissue, and phylogenetic distribution. J. Neurosci. 6, 1469–1481 (1986)
    Article CAS Google Scholar
  22. Liu, F. et al. Regulation of cyclin-dependent kinase 5 and casein kinase 1 by metabotropic glutamate receptors. Proc. Natl Acad. Sci. USA 98, 11062–11068 (2001)
    Article CAS Google Scholar
  23. Rimondini, R., Ferré, S., Giménez-Llort, L., Ögren, S.-O. & Fuxe, K. Differential effects of selective adenosine A1 and A2 receptor agonists on dopamine receptor agonist-induced behavioural responses in rats. Eur. J. Pharmacol. 347, 153–158 (1998)
    Article CAS Google Scholar
  24. Kafka, S. H. & Corbett, R. Selective adenosine A2A receptor/dopamine D2 receptor interactions in animal models of schizophrenia. Eur. J. Pharmacol. 295, 147–154 (1996)
    Article CAS Google Scholar
  25. Svenningsson, P. et al. Regulation of the phosphorylation of the dopamine- and cAMP-regulated phosphoprotein of 32 kDa in vivo by dopamine D1, dopamine D2, and adenosine A2A receptors. Proc. Natl Acad. Sci. USA 97, 1856–1860 (2000)
    Article CAS Google Scholar

Download references